Latest news
Loading news…
Myomar Molecular
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Halifax, Nova Scotia, Canada Founded 2021 1-10 employees For Profit
Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Testing
- IT spend
- $158.63K
Company Info
- Founded
- 2021
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 17
- HQ
- Halifax, Nova Scotia, Canada
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- -0.4
- Trend (30d)
- -4.4
- Trend (90d)
- 4.7
Key People at Myomar Molecular
Co-Founder and CEO
1
professional contacts at Myomar Molecular
Contact execs at Myomar Molecular →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Myomar Molecular
Loading news…
FAQs about Myomar Molecular
People who checked this page also checked these
Browse the full Acquirezy directory.